Home
VERA
VERA News

Latest Vera Therapeutics Inc. (VERA) News on November 17, 2024

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 days ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet

Zacks

6 days ago

Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet

Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study

GlobeNewswire

6 days ago

Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study

Vera Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire

9 days ago

Vera Therapeutics to Participate at Upcoming Investor Conferences

Vera Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire

9 days ago

Vera Therapeutics to Participate at Upcoming Investor Conferences

MT Newswires

9 days ago

Wedbush Raises Vera Therapeutics' Price Target to $38 From $30, Maintains Neutral rating

MT Newswires

10 days ago

Vera Therapeutics Shares Rise After Q3 Results

Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

10 days ago

Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

GlobeNewswire

19 days ago

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

Vera Therapeutics price target raised to $64 from $56 at Guggenheim

TipRanks

19 days ago

Vera Therapeutics price target raised to $64 from $56 at Guggenheim

Vera Therapeutics Breaks Out On Promising Results For Kidney Drug

Investor's Business Daily

20 days ago

Vera Therapeutics Breaks Out On Promising Results For Kidney Drug

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

GlobeNewswire

20 days ago

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

MT Newswires

20 days ago

Vera Therapeutics Shares Jump After Supportive Data From Phase 2b Trial of Kidney Disease Drug Candidate

Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years

Benzinga

20 days ago

Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years

Vera Therapeutics Eyes Breakout On Promising Results For Kidney Drug

Investor's Business Daily

20 days ago

Vera Therapeutics Eyes Breakout On Promising Results For Kidney Drug

Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

GlobeNewswire

22 days ago

Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

MT Newswires

a month ago

Scotiabank Initiates Vera Therapeutics at Sector Outperform

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

2 months ago

Vera Therapeutics Expands Development of Kidney Disease Drug Pipeline

Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024

GlobeNewswire

2 months ago

Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024

Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases

GlobeNewswire

2 months ago

Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases

Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024?

Insider Monkey

2 months ago

Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024?

Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024

GlobeNewswire

2 months ago

Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024

Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN

GlobeNewswire

2 months ago

Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy Now

Insider Monkey

2 months ago

Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy Now

Adobe Stock Added to JP Morgan Focus List. Here’s Why.

Barrons.com

2 months ago

Adobe Stock Added to JP Morgan Focus List. Here’s Why.

Adobe and 2 More Stocks Added to JP Morgan Focus List. Here’s Why.

Barrons.com

2 months ago

Adobe and 2 More Stocks Added to JP Morgan Focus List. Here’s Why.

Vera Therapeutics to Participate at September Investor Conferences

GlobeNewswire

3 months ago

Vera Therapeutics to Participate at September Investor Conferences

Vera Therapeutics, Inc.'s (NASDAQ:VERA) Intrinsic Value Is Potentially 88% Above Its Share Price

Simply Wall St.

3 months ago

Vera Therapeutics, Inc.'s (NASDAQ:VERA) Intrinsic Value Is Potentially 88% Above Its Share Price

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

3 months ago

Wedbush Cuts Vera Therapeutics' Price Target to $30 From $32, Maintains Neutral rating

Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

5 months ago

Vera Therapeutics Appoints David Johnson as Chief Operating Officer

Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer

GlobeNewswire

5 months ago

Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer

Vera Therapeutics Appoints Christy J. Oliger to Board of Directors

GlobeNewswire

5 months ago

Vera Therapeutics Appoints Christy J. Oliger to Board of Directors

Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

5 months ago

Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

6 months ago

Vera Therapeutics Gets FDA Breakthrough Therapy Designation for Immunoglobulin A Nephropathy Treatment

Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)

GlobeNewswire

6 months ago

Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress

GlobeNewswire

6 months ago

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress

MT Newswires

6 months ago

Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing

MT Newswires

6 months ago

Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week

Simply Wall St.

6 months ago

Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week

Health Care Roundup: Market Talk

The Wall Street Journal

7 months ago

Health Care Roundup: Market Talk

Could This Stock Be the Next Biotech Buyout?

Motley Fool

7 months ago

Could This Stock Be the Next Biotech Buyout?

Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

GuruFocus.com

7 months ago

Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal

Yahoo Finance Video

7 months ago

Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Barrons.com

7 months ago

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress

GlobeNewswire

7 months ago

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

8 months ago

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference

GlobeNewswire

9 months ago

Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference

Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)

Simply Wall St.

9 months ago

Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)

Wall Street Analysts Think Dave & Buster's (PLAY) Is a Good Investment: Is It?

Zacks

9 months ago

Wall Street Analysts Think Dave & Buster's (PLAY) Is a Good Investment: Is It?

Vera Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

9 months ago

Vera Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Leslie’s, Inc. Announces First Quarter Fiscal 2024 Financial Results

GlobeNewswire

10 months ago

Leslie’s, Inc. Announces First Quarter Fiscal 2024 Financial Results

Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock

GlobeNewswire

10 months ago

Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock

Factors Setting the Tone for Vista Outdoor (VSTO) Q3 Earnings

Zacks

10 months ago

Factors Setting the Tone for Vista Outdoor (VSTO) Q3 Earnings

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

GlobeNewswire

10 months ago

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

Why Is Fiverr (FVRR) Stock Rocketing Higher Today

StockStory

10 months ago

Why Is Fiverr (FVRR) Stock Rocketing Higher Today

Protagonist Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2024

ACCESSWIRE

10 months ago

Protagonist Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2024

Bank of America: Buy, Sell, or Hold?

Motley Fool

10 months ago

Bank of America: Buy, Sell, or Hold?

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

GlobeNewswire

10 months ago

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

3 Great Dividend Stocks to Spice Up Your Portfolio

Motley Fool

10 months ago

3 Great Dividend Stocks to Spice Up Your Portfolio

Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend

Business Wire

10 months ago

Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend

Reuters

10 months ago

TABLE-LNG tankers heading to Britain, Belgium, the Netherlands and Germany

Reuters

10 months ago

UPDATE 4-Texas Freeport LNG unit faces month-long outage after winter storm

Reuters

10 months ago

UPDATE 3-Biden pauses LNG export approvals after pressure from climate activists

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

Zacks

10 months ago

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

Business Wire

10 months ago

AMTD Digital’s Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit

Reuters

10 months ago

GLOBAL LNG-Asia spot prices remain flat below $10/mmBtu despite geopolitical risks

Biogas Traders Become Hot Commodities on Demand for Clean Fuel

Bloomberg

10 months ago

Biogas Traders Become Hot Commodities on Demand for Clean Fuel

Q3 Earnings Roundup: Boston Beer (NYSE:SAM) And The Rest Of The Beverages and Alcohol Segment

StockStory

10 months ago

Q3 Earnings Roundup: Boston Beer (NYSE:SAM) And The Rest Of The Beverages and Alcohol Segment

Business Wire

10 months ago

AMTD Digital’s Half Yearly Net Profit is Estimated to Increase over 150% Year over Year

Associated Press Finance

10 months ago

Lakeland Bancorp: Q4 Earnings Snapshot

Lakeland Bancorp Announces Quarterly and Year-End 2023 Earnings

GlobeNewswire

10 months ago

Lakeland Bancorp Announces Quarterly and Year-End 2023 Earnings

Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy

GlobeNewswire

10 months ago

Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy

Reuters

10 months ago

UPDATE 1-US FDA still reviewing Liquidia's inhaled blood pressure drug

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

GlobeNewswire

10 months ago

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

Newsfile

10 months ago

Seabridge Gold Supports 'Close to Home' Tier 3 Neonatal Intensive Care Unit

Fiverr International (FVRR) Stock Dips While Market Gains: Key Facts

Zacks

10 months ago

Fiverr International (FVRR) Stock Dips While Market Gains: Key Facts

Frontier Group Holdings Announces Webcast of Fourth Quarter 2023 Financial Results

GlobeNewswire

10 months ago

Frontier Group Holdings Announces Webcast of Fourth Quarter 2023 Financial Results

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

Business Wire

10 months ago

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

18 High Growth Low PE Stocks

Insider Monkey

10 months ago

18 High Growth Low PE Stocks

Why Unum (UNM) Outpaced the Stock Market Today

Zacks

10 months ago

Why Unum (UNM) Outpaced the Stock Market Today

3 Cheap Industrial Stocks Primed to Ride an Infrastructure Boom

InvestorPlace

10 months ago

3 Cheap Industrial Stocks Primed to Ride an Infrastructure Boom

Agilysys Inc (AGYS) Reports Record Revenue Growth in Q3 Fiscal 2024

GuruFocus.com

10 months ago

Agilysys Inc (AGYS) Reports Record Revenue Growth in Q3 Fiscal 2024

HCI Group Takes Strategic Steps to Better Position Company for Future Opportunities

GlobeNewswire

10 months ago

HCI Group Takes Strategic Steps to Better Position Company for Future Opportunities

Northwest Bancshares (NWBI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

10 months ago

Northwest Bancshares (NWBI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks

GlobeNewswire

10 months ago

Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks

The 3 Most Undervalued AI Stocks to Buy in January

InvestorPlace

10 months ago

The 3 Most Undervalued AI Stocks to Buy in January

Vehicle Retailer Q3 Earnings: Camping World (NYSE:CWH) is the Best in the Biz

StockStory

10 months ago

Vehicle Retailer Q3 Earnings: Camping World (NYSE:CWH) is the Best in the Biz

Digi International to Release First Fiscal Quarter 2024 Earnings Results on January 31, 2024 and Host a Conference Call on February 1, 2024

Business Wire

10 months ago

Digi International to Release First Fiscal Quarter 2024 Earnings Results on January 31, 2024 and Host a Conference Call on February 1, 2024

Why Accolade (ACCD) Stock Might be a Great Pick

Zacks

10 months ago

Why Accolade (ACCD) Stock Might be a Great Pick

Oil Prices Rise on EIA Supply Data, IEA Demand Forecast

Zacks

10 months ago

Oil Prices Rise on EIA Supply Data, IEA Demand Forecast

Liquidia Corporation Announces Updates to Operations Leadership

GlobeNewswire

10 months ago

Liquidia Corporation Announces Updates to Operations Leadership

Ichor Holdings (ICHR) Surges 9.0%: Is This an Indication of Further Gains?

Zacks

10 months ago

Ichor Holdings (ICHR) Surges 9.0%: Is This an Indication of Further Gains?

Share on Social Networks: